Emergent Biosolutions Inc. Stock
A loss of -1.050% shows a downward development for Emergent Biosolutions Inc..
Emergent Biosolutions Inc. is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 13 € there is a hugely positive potential of 84.24% for Emergent Biosolutions Inc. compared to the current price of 7.06 €.
Our community identified positive and negative aspects for Emergent Biosolutions Inc. stock for the coming years. 1 users see the criterium "Company culture" as a plus for the Emergent Biosolutions Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Emergent Biosolutions Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Emergent Biosolutions Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc. | -1.050% | -3.050% | -22.767% | 24.620% | -32.089% | -22.589% | -90.654% |
| United Therapeutics | -0.830% | 10.795% | 15.436% | 64.674% | 8.331% | 115.202% | 245.448% |
| Iovance Biotherapeutics Inc. | -14.490% | -10.934% | 66.172% | 0.944% | 48.693% | -39.544% | -87.848% |
| Ligand Pharmaceuticals | -6.250% | 1.667% | 16.561% | 69.444% | 10.241% | 172.971% | 33.091% |
Comments
Emergent Biosolutions (NYSE:EBS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for EBS provided by MarketBeat
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for EBS provided by MarketBeat